255 related articles for article (PubMed ID: 16024653)
21. Overexpression of cyclins D1 and D3 during estrogen-induced breast oncogenesis in female ACI rats.
Weroha SJ; Li SA; Tawfik O; Li JJ
Carcinogenesis; 2006 Mar; 27(3):491-8. PubMed ID: 16311245
[TBL] [Abstract][Full Text] [Related]
22. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
Bartkova J; Lukas J; Müller H; Strauss M; Gusterson B; Bartek J
Cancer Res; 1995 Feb; 55(4):949-56. PubMed ID: 7850812
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation.
Chen Q; Lin J; Jinno S; Okayama H
Oncogene; 2003 Feb; 22(7):992-1001. PubMed ID: 12592386
[TBL] [Abstract][Full Text] [Related]
24. G1-phase regulators, cyclin D1, cyclin D2, and cyclin D3: up-regulation at gastrulation and dynamic expression during neurulation.
Wianny F; Real FX; Mummery CL; Van Rooijen M; Lahti J; Samarut J; Savatier P
Dev Dyn; 1998 May; 212(1):49-62. PubMed ID: 9603423
[TBL] [Abstract][Full Text] [Related]
25. The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids.
Li Y; Glozak MA; Smith SM; Rogers MB
Exp Cell Res; 1999 Dec; 253(2):372-84. PubMed ID: 10585260
[TBL] [Abstract][Full Text] [Related]
26. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
[TBL] [Abstract][Full Text] [Related]
27. D-type cyclins and G1 progression during liver development in the rat.
Boylan JM; Gruppuso PA
Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
[TBL] [Abstract][Full Text] [Related]
28. D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability.
Knudsen KE; Cavenee WK; Arden KC
Cancer Res; 1999 May; 59(10):2297-301. PubMed ID: 10344732
[TBL] [Abstract][Full Text] [Related]
29. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
Yu Q; Ciemerych MA; Sicinski P
Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
[TBL] [Abstract][Full Text] [Related]
30. ARA54 is involved in transcriptional regulation of the cyclin D1 gene in human cancer cells.
Kikuchi H; Uchida C; Hattori T; Isobe T; Hiramatsu Y; Kitagawa K; Oda T; Konno H; Kitagawa M
Carcinogenesis; 2007 Aug; 28(8):1752-8. PubMed ID: 17510080
[TBL] [Abstract][Full Text] [Related]
31. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis.
Sicinski P; Donaher JL; Geng Y; Parker SB; Gardner H; Park MY; Robker RL; Richards JS; McGinnis LK; Biggers JD; Eppig JJ; Bronson RT; Elledge SJ; Weinberg RA
Nature; 1996 Dec; 384(6608):470-4. PubMed ID: 8945475
[TBL] [Abstract][Full Text] [Related]
32. Mouse development and cell proliferation in the absence of D-cyclins.
Kozar K; Ciemerych MA; Rebel VI; Shigematsu H; Zagozdzon A; Sicinska E; Geng Y; Yu Q; Bhattacharya S; Bronson RT; Akashi K; Sicinski P
Cell; 2004 Aug; 118(4):477-91. PubMed ID: 15315760
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro.
Zhou Q; Stetler-Stevenson M; Steeg PS
Oncogene; 1997 Jul; 15(1):107-15. PubMed ID: 9233783
[TBL] [Abstract][Full Text] [Related]
34. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
[TBL] [Abstract][Full Text] [Related]
35. Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism.
Langenfeld J; Kiyokawa H; Sekula D; Boyle J; Dmitrovsky E
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12070-4. PubMed ID: 9342364
[TBL] [Abstract][Full Text] [Related]
36. Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma.
Pirkmaier A; Dow R; Ganiatsas S; Waring P; Warren K; Thompson A; Hendley J; Germain D
Oncogene; 2003 Jul; 22(28):4425-33. PubMed ID: 12853979
[TBL] [Abstract][Full Text] [Related]
37. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1.
Kröger A; Stirnweiss A; Pulverer JE; Klages K; Grashoff M; Reimann J; Hauser H
Cancer Res; 2007 Apr; 67(7):2972-81. PubMed ID: 17409403
[TBL] [Abstract][Full Text] [Related]
38. The effect of cyclin D expression on cell proliferation in human gliomas.
Zhang X; Zhao M; Huang AY; Fei Z; Zhang W; Wang XL
J Clin Neurosci; 2005 Feb; 12(2):166-8. PubMed ID: 15749420
[TBL] [Abstract][Full Text] [Related]
39. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
40. Repression of cyclin D1 as a target for germ cell tumors.
Freemantle SJ; Vaseva AV; Ewings KE; Bee T; Krizan KA; Kelley MR; Hattab EM; Memoli VA; Black CC; Spinella MJ; Dmitrovsky E
Int J Oncol; 2007 Feb; 30(2):333-40. PubMed ID: 17203214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]